leisure time -WSS

leisure time

author：entertainment 2025-08-27 16:48:08 - browse：6198

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Humana, CVS hope to turn members into patients at clinics

WSS

Will the market for weight loss drugs really reach $100 billion?

Mayo Clinic plans $5B tech

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

As biotech industry slumps, bioscience job market is upside down

What to do when lifesaving products contribute to climate change

Diagnostic tests are hitting their mathematical limits

focus

leisure time

knowledge

Sports medicine is finally prioritizing gender equality

Organ aging and disease risk measured by new blood test

Hepatitis C has a cure — but many Americans still lack access to it

Cigna, Humana reportedly in talks to merge

Jerome Adams on the need for new antivirals for Covid

ProMED, early warning system on disease outbreaks, in peril

Continuity nursing helped my family in our darkest PICU moments

How to pay for weight loss drugs and save Medicare

Medical records are filled with copy

CDC director unscathed in first congressional testimony

knowledge

CDC director unscathed in first congressional testimony

Organ aging and disease risk measured by new blood test

What don’t we know about an Alzheimer’s drug side effect?

BIO selects John Crowley as new CEO

What Mike Pence has said that could be used in a Donald Trump trial

Flagship Pioneering launches a new biotech in two countries

hotspot

focus

hotspot

hotspot